Simplex Trading’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-195
Closed -$5K 11127
2021
Q1
$5K Buy
195
+98
+101% +$69 ﹤0.01% 8240
2020
Q4
$4K Hold
97
﹤0.01% 7840
2020
Q3
$5K Buy
+97
New +$70 ﹤0.01% 7158
2020
Q2
Sell
-27
Closed -$2K 8725
2020
Q1
$2K Sell
27
-1
-4% -$1 ﹤0.01% 7283
2019
Q4
$4K Buy
+28
New +$42 ﹤0.01% 6831
2019
Q1
Sell
-14
Closed -$1K 8206
2018
Q4
$1K Sell
14
-37
-73% -$55 ﹤0.01% 6848
2018
Q3
$6K Buy
51
+14
+38% +$22 ﹤0.01% 6726
2018
Q2
$8K Buy
+37
New +$71 ﹤0.01% 6494
2017
Q1
Sell
-51
Closed -$1K 7071
2016
Q4
$1K Sell
51
-133
-72% -$438 ﹤0.01% 5617
2016
Q3
$7K Buy
+184
New +$423 ﹤0.01% 4019
2015
Q3
Sell
-45
Closed -$2K 6468
2015
Q2
$2K Buy
+45
New +$304 ﹤0.01% 4431

Simplex Trading's GEN Position: Q2 2021 in Review

Simplex Trading sold out of Genesis Healthcare, Inc. (GEN) in Q2 2021, closing a stake of 4,700 shares — an estimated $1K sold.

Simplex Trading first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $6K in Q1 2015. 1 fund tracked by Wall St. Rank holds GEN as of Q2 2021.

  • Simplex Trading reported no remaining Genesis Healthcare, Inc. position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 4,700 Genesis Healthcare, Inc. shares in Q2 2021, an estimated $1K.
  • Simplex Trading first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
  • Simplex Trading's Genesis Healthcare, Inc. position peaked at $6K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.